Indications for Treating Subclinical Hypothyroidism
Definite Indications for Treatment
- Patients with subclinical hypothyroidism and TSH levels consistently above 10 mIU/L should receive levothyroxine therapy due to higher risk of progression to overt hypothyroidism (5% per year) 1, 2
- All pregnant women with subclinical hypothyroidism should be treated regardless of TSH level to reduce risks of pregnancy complications and potential adverse effects on fetal neurocognitive development 4
Consider Treatment in TSH 4.5-10 mIU/L with:
- Symptomatic patients with symptoms compatible with hypothyroidism may benefit from a trial of levothyroxine, though improvement should be carefully evaluated to distinguish from placebo effect 1, 3, 5
- Patients with positive TPO antibodies, indicating autoimmune etiology and higher risk of progression to overt hypothyroidism (4.3% vs 2.6% per year in antibody-negative individuals) 1, 3
Monitoring Without Treatment (TSH 4.5-10 mIU/L)
- For patients with TSH between 4.5-10 mIU/L without risk factors, monitoring with thyroid function tests at 6-12 month intervals is recommended 1, 2, 3
Evaluation Before Treatment
- Confirm diagnosis with repeat TSH and FT4 measurement after 2 weeks to 3 months 3, 5
- Evaluate for signs/symptoms of hypothyroidism, previous thyroid treatment, thyroid enlargement, and family history of thyroid disease 1, 3
- Review lipid profiles as subclinical hypothyroidism may affect cholesterol levels 1, 3